>

Amedisys Stock Profile

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:4em;padding-top: 25px;;'>AM</div>

Performance

12 / 100

Odds of Distress

Equity ratings for Amedisys are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 27, 2019 and ending today February 25, 2020. Click here to learn more.

Amedisys Profile

Next fiscal quarter end is expected on March 31, 2020. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana. Amedisys operates under Medical Care Facilities classification in USA and is traded on BATS Exchange. It employs 21000 people. more on Amedisys
Amedisys Fama & French Healthcare
Healthcare
Fama & French Classification
Amedisys SEC Filings
Amedisys SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameAmedisys
CEO and President and DirectorPaul KusserowView All
Thematic Classification
Currently Active Investing Idea
  Healthcare
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Amedisys
Piotroski F Score
Academic score to determine the current strength of Amedisys financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Amedisys ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of Amedisys representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Amedisys (AMED) is traded on BATS Exchange in USA. It is located in 3854 American Way and employs 21,000 people. Amedisys is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with current market capitalization of 4.15 B. Amedisys conducts business under Healthcare sector and is part of Medical Care Facilities industry. The entity has 32.26 M outstanding shares of which 1.25 M shares are presently shorted by private and institutional investors with about 6.25 trading days to cover. AMEDISYS INC currently holds about 20.76 M in cash with 169.07 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64.
Check Amedisys Probability Of Bankruptcy

Ownership Allocation (%)

Amedisys Stock Price Odds Analysis

Odds Below 185.24HorizonTargetOdds Above 185.24
81.59%30 days 185.24 18.29%
Based on normal probability distribution, the odds of Amedisys to move above current price in 30 days from now is about 18.29 (This Amedisys probability density function shows the probability of Amedisys Stock to fall within a particular range of prices over 30 days) .

Amedisys Stock Top Holders

Amedisys Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares4.4 M729.3 M
Vanguard Group IncCommon Shares3.1 M524.2 M
View Amedisys Diagnostics

Amedisys Income Statement Over Time

Amedisys Stock Against Markets

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Amedisys Upcoming and Recent Events

Amedisys Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportMay 5, 2020
Next Earnings ReportJuly 29, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 16, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019

Amedisys Corporate Filings

Amedisys SEC Reporting

Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
Unclassified Corporate Event
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Entry into a Material Definitive Agreement

Amedisys Corporate Directors

Jeffrey Rideout Director
Nathaniel Zilkha Director
Bruce Perkins Independent Director
Please continue to Trending Equities. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.
Company logos by clearbit